Literature DB >> 20082474

Pulmonary involvement and allergic disorders in inflammatory bowel disease.

Nikolaos E Tzanakis1, Ioanna G Tsiligianni, Nikolaos M Siafakas.   

Abstract

Inflammatory bowel disease (IBD) has been associated with either clinical or subclinical airway and parenchymal lung involvement and interstitial lung complications. Several studies have reported that atopy has a high prevalence in IBD patients. Overlapping allergic disorders seem to be present in both the respiratory and gastrointestinal systems. The purpose of this review is to update clinicians on recent available literature and to discuss the need for a highly suspicious approach by clinicians.

Entities:  

Mesh:

Year:  2010        PMID: 20082474      PMCID: PMC2807949          DOI: 10.3748/wjg.v16.i3.299

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  123 in total

Review 1.  Genetic factors associated with the development of inflammatory bowel disease.

Authors:  Jesus-K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

2.  Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD.

Authors:  Anders Ekbom; Lena Brandt; Fredrik Granath; Claes-Göran Löfdahl; Arne Egesten
Journal:  Lung       Date:  2008-03-11       Impact factor: 2.584

3.  Effect of smoking on chronic inflammatory bowel disease.

Authors:  G K Potter
Journal:  J R Soc Health       Date:  1995-06

4.  Changes in pulmonary function in patients with ulcerative colitis.

Authors:  Aliaë A R Mohamed-Hussein; Nadia A S Mohamed; Mohamed-Eltaher A R Ibrahim
Journal:  Respir Med       Date:  2006-10-17       Impact factor: 3.415

5.  Induced sputum eosinophilia in ulcerative colitis patients: the lung as a mirror image of intestine?

Authors:  Elizabeth Fireman; Farid Masarwy; Gabi Groisman; Moshe Shtark; Yael Kopelman; Shmuel Kivity; Zvi Fireman
Journal:  Respir Med       Date:  2009-02-20       Impact factor: 3.415

6.  Inflammatory bowel disease in relation to contact allergy: a patient-based study.

Authors:  Kåre Engkilde; Torkil Menné; Jeanne Duus Johansen
Journal:  Scand J Gastroenterol       Date:  2007-05       Impact factor: 2.423

7.  Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.

Authors:  Zhanju Liu; Li Yang; Yi Cui; Xingpeng Wang; Chuanyong Guo; Zhigang Huang; Quancheng Kan; Zhangsuo Liu; Yulan Liu
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

Review 8.  T cell trafficking in allergic asthma: the ins and outs.

Authors:  Benjamin D Medoff; Seddon Y Thomas; Andrew D Luster
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 9.  Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD?

Authors:  Sunny Singh; Lesley A Graff; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2009-03-31       Impact factor: 10.864

10.  Prevalence of inflammatory bowel disease in patients with airways disease.

Authors:  A A Raj; S S Birring; R Green; A Grant; J de Caestecker; I D Pavord
Journal:  Respir Med       Date:  2008-03-05       Impact factor: 3.415

View more
  11 in total

1.  Pulmonary manifestations in inflammatory bowel disease: a prospective study.

Authors:  Devendra Desai; Samir Patil; Zarir Udwadia; Shailendra Maheshwari; Philip Abraham; Anand Joshi
Journal:  Indian J Gastroenterol       Date:  2011-09-21

Review 2.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 3.  Noninfectious interstitial lung disease during infliximab therapy: case report and literature review.

Authors:  Roberta Caccaro; Edoardo Savarino; Renata D'Incà; Giacomo Carlo Sturniolo
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

Review 4.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

5.  Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages.

Authors:  Esmaeil Mortaz; Ian M Adcock; Fabio L M Ricciardolo; Mohammad Varahram; Hamidreza Jamaati; Ali Akbar Velayati; Gert Folkerts; Johan Garssen
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Sebastian Majewski; Wojciech Piotrowski
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

7.  Pulmonary dysfunction in 114 patients with inflammatory bowel disease.

Authors:  Yujie Zhao; Junshan Wang; Zhanju Liu; Hui Lin; Yanhong Shi; Xiaomin Sun
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

Review 8.  Probiotics in the management of lung diseases.

Authors:  Esmaeil Mortaz; Ian M Adcock; Gert Folkerts; Peter J Barnes; Arjan Paul Vos; Johan Garssen
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

9.  Pulmonary function and methacholine challenge tests in patients with ulcerative colitis.

Authors:  Maryam Taherzadeh; Homayoon Vahedi; Keivan Gohari Moghadam; Javad Shakeri; Mehedi Chaharmahali; Omalbanin Paknejad
Journal:  Tanaffos       Date:  2012

Review 10.  Inflammatory bowel disease and airway diseases.

Authors:  Maria Vutcovici; Paul Brassard; Alain Bitton
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.